Ultimas Noticias


Kits LightMix® para diagnóstico

A finales del 2008 hemos firmado un acuerdo con Roche Diagnostics.

End of 2008 we have signed a license agreement with Roche Diagnostics which allows us to develop and offer in-vitro diagnostic PCR tests using fluorescent probes.

The k-ras codon 12/13 mutation detection kit is our first CE-labeled product - intended for the analysis of tumor samples for selection of treatment with EGF antibody based therapeutics.

ArchivoArchivo